Microbiome Innovation In Dubai: IP-Focused R&D Ecosystem To Lead Global Health

Dubai Future Foundation, Dubai Department of Economy and Tourism, and Crescent Enterprises have launched a new research and development initiative in Dubai called the ‘Global Microbiome Ecosystem’. The Dubai-based platform targets microbiome science for health, longevity, and wellness, with a strong focus on intellectual property creation and international impact.

The initiative is linked to the UAE’s wider ‘Future of Health’ agenda, which treats health innovation as an engine for economic growth, improved quality of life, and stronger global competitiveness. The ‘Global Microbiome Ecosystem’ is designed to attract researchers, investors, and policymakers to Dubai, creating a connected hub for microbiome-focused health solutions.

According to the partners, the Global Microbiome Ecosystem will function as an IP-focused platform centred in Dubai but serving global markets. It will connect microbiome-driven health innovation with structured R&D, specialised talent programmes, and strategic partnerships. The aim is to speed up knowledge creation, support responsible clinical use, and generate high-value intellectual property across the longevity and wellness sectors.

Khalifa Al Qama, Chief of Research, Development and Innovation at Dubai RDI, an ecosystem under Dubai Future Foundation, said: "Dubai’s innovation and regulatory sandbox frameworks position the city as a natural home for the global microbiome sector, enabling a connected ecosystem that brings together research institutions, innovators, investors, policymakers, and global partners.

By focusing on microbiome-driven health and longevity, this collaboration can accelerate translational research, create globally relevant intellectual property, and reinforce Dubai’s role as a leading hub where frontier science is translated into real-world health impact."

Dubai RDI, operating under Dubai Future Foundation, will work with Crescent Enterprises and the Dubai Department of Economy and Tourism to align regulation, investment, and research activity. Their shared goal is to support microbiome science that can translate into precision health solutions and services, while keeping global standards and ethical practice in view.

The cooperation builds on Crescent Enterprises’ experience as an investor in microbiome-focused ventures and as a host of international expertise. The partners plan to explore routes for new microbiome-based products and services, including approaches to clinical testing, regulatory approval, and scaling to international markets, with Dubai acting as a central base.

Global Microbiome Ecosystem and the microbiome ‘moonshot’

Badr Jafar, CEO of Crescent Enterprises, framed the launch within a critical phase for the field. Badr Jafar said: "We are at a microbiome ‘moonshot’ moment – a point where science, technology, and collaboration can converge and where choices we make now will shape outcomes for decades to come. Dubai and the UAE are a natural base for this as a leading global hub not just for trade and capital, but for ideas, talent, and science. Translating breakthrough science into real-world impact requires exactly this kind of alignment – across research, innovation, policy, and investment."

The announcement for the Global Microbiome Ecosystem took place during the opening of "The Microbiome Revolution: Unlocking the Gut–Brain Axis for the Future of Health". The symposium, hosted by CE-Ventures, the corporate venture capital arm of Crescent Enterprises, gathered more than 150 participants including scientists, clinicians, entrepreneurs, investors, and policymakers.

Discussions at the Microbiome Revolution symposium focused on how gut–brain axis research is changing approaches to prevention, mental wellbeing, and personalised care. Speakers examined ways microbiome science could support precision health models, from diagnostics to tailored treatments, and how platforms such as the Global Microbiome Ecosystem might help move such work into clinical practice.

The event also underlined the importance of coordination between public bodies and private sector actors when building next-generation health systems. Participants highlighted the UAE’s position as a venue where global experts can meet, exchange data and experience, and link breakthrough science with practical, scalable health solutions that can be deployed in Dubai and beyond.

Through the Global Microbiome Ecosystem and related initiatives, Dubai and the UAE are positioning microbiome-driven health and longevity research as a strategic priority. The partners expect that the new platform will support IP creation, attract specialised talent, and reinforce Dubai’s status as a hub where advanced health science is translated into real-world outcomes.

With inputs from WAM